7th International Congress of Cardionephrology KARNEF (2025) [pp. 74-81]
AUTHOR(S) / АУТОР(И): Alexandros Kallifatidis 
Download Full Pdf 
DOI: 10.46793/KARNEF25.076K
ABSTRACT / САЖЕТАК:
Cardiorenal syndrome (CRS) refers to the intricate bidirectional relationship between the heart and kidneys, wherein acute or chronic dysfunction in one organ precipitates dysfunction in the other. This interaction is classified into five distinct subtypes, based on the primary organ affected and the chronicity of the condition. Key clinical challenges in managing CRS include the absence of effective tools for early diagnosis, prognosis, and the evaluation of therapeutic outcomes. Imaging modalities such as ultrasound, computed tomography (CT), nuclear medicine, and magnetic resonance imaging (MRI) are increasingly utilized to assess cardiovascular and renal diseases. The technological advancements of the past few decades have accelerated the development of sophisticated imaging techniques, offering promising biomarkers for morpho-functional evaluation and tissue characterization. It is essential for clinicians to be aware of the advantages, limitations, and clinical utility of each modality in the management of CRS.
KEYWORDS / КЉУЧНЕ РЕЧИ:
cardiovascular mri, T1 mapping, atherosclerosis, hypertension, diabetes melitus, obesity, stress perfusion cmr, regadenoson
REFERENCES / ЛИТЕРАТУРА:
- Ronco, C.; McCullough, P.; Anker, S.D.; Anand, I.; Aspromonte, N.; Bagshaw, S.M.; Bellomo, R.; Berl, T.; Bobek, I.; Cruz, D.N.; et al. Cardio-renal syndromes: Report from the consensus conference of the acute dialysis quality initiative. Heart J. 2010, 31, 703–711. https://doi.org/10.1093/eurheartj/ehp507
- Lin L, Zhou X, Dekkers IA, Lamb HJ. Cardiorenal Syndrome: Emerging Role of Medical Imaging for Clinical Diagnosis and Management. J Pers Med. 2021 Jul 28;11(8):734. https://doi.org/10.3390/jpm11080734
- Xu J, Yang W, Zhao S, Lu M. State-of-the-art myocardial strain by CMR feature tracking: clinical applications and future perspectives. Eur Radiol. 2022 Aug;32(8):5424-5435. doi: https://doi.org/10.1007/s00330-022-08629-2 Epub 2022 Feb 24. PMID: 35201410.
- Zannad F, Rossignol P. Circulation. 2018 Aug 28;138(9):929-944. https://doi.org/10.1161/CIRCULATIONAHA.117.028814 PMID: 30354446 Review.
- Aurélie Huber, Ibtisam Aslam, Lindsey Crowe, Menno Pruijm, Thomas de Perrot, Sophie de Seigneux, Jean-Paul Vallée, Lena Berchtold, T1 mapping magnetic resonance imaging predicts decline of kidney function, Clinical Kidney Journal, 2025;, sfaf032, https://doi.org/10.1093/ckj/sfaf032
- Bornstein AB, Rao SS, Marwaha K. Left Ventricular Hypertrophy. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan https://www.ncbi.nlm. nih.gov/books/NBK557534/
- Counseller Q, Aboelkassem Y. Recent technologies in cardiac imaging. Front Med Technol. 2023 Jan 10;4:984492. doi: 10.3389/fmedt.2022.984492. PMID: 36704232; PMCID: PMC9872125.
- Wu J, Shi Z, Zhang Y, Yan J, Shang F, Wang Y, Lu H, Gu H, Dou W, Wang X, Yuan L. Native T1 Mapping in Assessing Kidney Fibrosis for Patients With Chronic Glomerulonephritis. Front Med (Lausanne). 2021 Oct 18;8:772326. doi: 10.3389/fmed.2021.772326. PMID: 34733870; PMCID: PMC8558353.
- Cox EF, Buchanan CE, Bradley CR, Prestwich B, Mahmoud H, Taal M, Selby NM, Francis ST. Multiparametric Renal Magnetic Resonance Imaging: Validation, Interventions, and Alterations in Chronic Kidney Disease. Front Physiol. 2017 Sep 14;8:696. doi: 10.3389/fphys.2017.00696. PMID: 28959212; PMCID: PMC5603702.
- Elkholy KO, Hegazy O, Okunade A, Aktas S, Ajibawo T. Regadenoson Stress Testing: A Comprehensive Review With a Focused Update. Cureus. 2021 Jan 27;13(1):e12940. doi: 10.7759/cureus.12940. PMID: 33654619; PMCID: PMC7909893